%0 Journal Article
%T Update on triple therapy for eradication of Helicobacter pylori: current status of the art
%A Urgesi R
%A Cianci R
%A Riccioni ME
%J Clinical and Experimental Gastroenterology
%D 2012
%I Dove Medical Press
%R http://dx.doi.org/10.2147/CEG.S25416
%X ate on triple therapy for eradication of Helicobacter pylori: current status of the art Review (2054) Total Article Views Authors: Urgesi R, Cianci R, Riccioni ME Published Date September 2012 Volume 2012:5 Pages 151 - 157 DOI: http://dx.doi.org/10.2147/CEG.S25416 Received: 18 March 2012 Accepted: 30 April 2012 Published: 17 September 2012 Riccardo Urgesi,1 Rossella Cianci,2 Maria Elena Riccioni3 1Gastroenterology and Endoscopy Unit, Viterbo, 2Institute of Internal Medicine, Catholic University of Rome, 3Digestive Endoscopy Unit, Catholic University of Rome, Rome, Italy Abstract: With the rising prevalence of antimicrobial resistance, the treatment success of standard triple therapy has recently declined to unacceptable levels (ie, 80% or less). Following the failure of conventional triple therapy, novel eradication regimens have been developed including sequential therapy, concomitant quadruple therapy, hybrid (dual-concomitant) therapy, bismuth-containing quadruple therapy, and a therapy with administration of N-acetylcysteine before a culture-guided antibiotic regimen. This article reviews the literature published on Helicobacter pylori eradication in the last year, focusing on the development of alternative strategies for first-, second-, and third-line rescue therapy for the eradication of H. pylori.
%K sequential therapy
%K quadruple therapy
%K concomitant therapy
%K hybrid therapy
%K N-acetylcysteine
%U https://www.dovepress.com/update-on-triple-therapy-for-eradication-of-helicobacter-pylori-curren-peer-reviewed-article-CEG